NAS:PODD (USA) Also trade in: Germany

Insulet Corp

$ 107.22 1.65 (1.56%)
Volume: 77,443 Avg Vol (1m): 694,783
Market Cap $: 6.42 Bil Enterprise Value $: 6.70 Bil
P/E (TTM): 467.67 P/B: 29.38
Earnings Power Value -9.66
Net Current Asset Value -3.8
Tangible Book 2.82
Projected FCF -6.59
Median P/S Value 67.16
Graham Number 3.82
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 5/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.53
Cash-To-Debt ranked higher than
61.21% of 330 companies
in the Medical Devices industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
PODD: 0.53
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.49, Med: 0.87, Max: 10000
Current: 0.53
0.49
10000
Equity-to-Asset 0.24
Equity-to-Asset ranked lower than
58.90% of 309 companies
in the Medical Devices industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
PODD: 0.24
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -2.37, Med: 0.24, Max: 0.73
Current: 0.24
-2.37
0.73
Debt-to-Equity 2.68
Debt-to-Equity ranked lower than
64.55% of 220 companies
in the Medical Devices industry.
Industry Max: 11.69, Med: 0.3, Min: 0.01
PODD: 2.68
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: -23.94, Med: 2.2, Max: 316.51
Current: 2.68
-23.94
316.51
Debt-to-EBITDA 9.83
Debt-to-EBITDA ranked lower than
68.99% of 158 companies
in the Medical Devices industry.
Industry Max: 3384.46, Med: 1.98, Min: 0.02
PODD: 9.83
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -8.05, Med: -2.64, Max: 237.18
Current: 9.83
-8.05
237.18
Interest Coverage 1.26
Interest Coverage ranked lower than
100.00% of 212 companies
in the Medical Devices industry.
Industry Max: 10000, Med: 66.37, Min: 0.03
PODD: 1.26
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 0.95, Med: 0.95, Max: 1.26
Current: 1.26
0.95
1.26
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.37
DISTRESS
GREY
SAFE
Beneish M-Score -2.50
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 6.47%
WACC 7.92%

Profitability & Growth : 6/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 5.78
Operating Margin ranked higher than
60.58% of 312 companies
in the Medical Devices industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
PODD: 5.78
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -89.89, Med: -14.41, Max: 5.78
Current: 5.78
-89.89
5.78
Net Margin % 2.37
Net Margin ranked higher than
57.69% of 312 companies
in the Medical Devices industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
PODD: 2.37
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -109.56, Med: -23.4, Max: 2.37
Current: 2.37
-109.56
2.37
ROE % 7.24
ROE ranked lower than
50.33% of 304 companies
in the Medical Devices industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
PODD: 7.24
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -178.71, Med: -60.48, Max: 7.24
Current: 7.24
-178.71
7.24
ROA % 1.60
ROA ranked higher than
59.64% of 332 companies
in the Medical Devices industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
PODD: 1.6
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -51.7, Med: -21.4, Max: 1.6
Current: 1.6
-51.7
1.6
ROC (Joel Greenblatt) % 16.45
ROC (Joel Greenblatt) ranked higher than
60.86% of 327 companies
in the Medical Devices industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
PODD: 16.45
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -217.31, Med: -82.41, Max: 16.45
Current: 16.45
-217.31
16.45
3-Year Total Revenue Growth Rate 28.80
3-Year Revenue Growth Rate ranked higher than
92.52% of 254 companies
in the Medical Devices industry.
Industry Max: 300.7, Med: 4.3, Min: -100
PODD: 25.8
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: 0, Med: 17.55, Max: 99.7
Current: 25.8
0
99.7

» PODD's 30-Y Financials

Financials (Next Earnings Date: 2019-08-02)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:PODD

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 339112    SIC : 3841
Compare NYSE:PEN HKSE:01066 NAS:IART NYSE:GMED OCSE:AMBU B SZSE:300529 NAS:WMGI NAS:TNDM OCSE:GN SZSE:002223 NAS:LIVN SZSE:300003 NAS:NUVA ASX:COH XSWX:TECN TSE:6849 NYSE:ITGR NAS:CNMD OCSE:OSSR TSE:8086
Traded in other countries GOV.Germany
Address 100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and a wireless personal diabetes manager that controls the dosage and has an integrated blood glucose meter. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, more than 20,000 insulin-dependent diabetics in the United States have begun using it.

Ratios

Current vs industry vs history
PE Ratio (TTM) 467.67
PE Ratio ranked lower than
100.00% of 180 companies
in the Medical Devices industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
PODD: 467.67
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 357.09, Med: 986.81, Max: 1842.92
Current: 467.67
357.09
1842.92
Forward PE Ratio 416.67
Forward P/E ranked lower than
100.00% of 52 companies
in the Medical Devices industry.
Industry Max: 454.55, Med: 25.06, Min: 3.33
PODD: 416.67
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 467.67
PE without NRI ranked lower than
100.00% of 179 companies
in the Medical Devices industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
PODD: 467.67
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 357.09, Med: 986.81, Max: 1842.92
Current: 467.67
357.09
1842.92
PB Ratio 29.38
PB Ratio ranked lower than
61.94% of 310 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
PODD: 29.38
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 3.13, Med: 22.64, Max: 1235
Current: 29.38
3.13
1235
PS Ratio 11.18
PS Ratio ranked lower than
55.78% of 294 companies
in the Medical Devices industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
PODD: 11.18
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 1.98, Med: 6.98, Max: 20.07
Current: 11.18
1.98
20.07
Price-to-Operating-Cash-Flow 151.73
Price-to-Operating-Cash-Flow ranked lower than
70.08% of 127 companies
in the Medical Devices industry.
Industry Max: 1586.78, Med: 20.01, Min: 3.03
PODD: 151.73
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 72.2, Med: 184.28, Max: 3931
Current: 151.73
72.2
3931
EV-to-EBIT 153.17
EV-to-EBIT ranked lower than
100.00% of 174 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
PODD: 153.17
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -867.9, Med: -26.5, Max: 4733.3
Current: 153.17
-867.9
4733.3
EV-to-EBITDA 109.83
EV-to-EBITDA ranked lower than
72.87% of 188 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
PODD: 109.83
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -404.9, Med: -23.85, Max: 1906
Current: 109.83
-404.9
1906
EV-to-Revenue 11.18
EV-to-Revenue ranked lower than
54.37% of 309 companies
in the Medical Devices industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
PODD: 11.18
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 2.3, Med: 7.3, Max: 19.7
Current: 11.18
2.3
19.7
Current Ratio 4.36
Current Ratio ranked higher than
90.74% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
PODD: 4.36
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.67, Med: 4.79, Max: 393.45
Current: 4.36
0.67
393.45
Quick Ratio 3.71
Quick Ratio ranked higher than
92.90% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
PODD: 3.71
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.56, Med: 4.39, Max: 393.45
Current: 3.71
0.56
393.45
Days Inventory 99.33
Days Inventory ranked higher than
88.78% of 294 companies
in the Medical Devices industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
PODD: 99.33
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 32.97, Med: 52.65, Max: 103.06
Current: 99.33
32.97
103.06
Days Sales Outstanding 41.78
Days Sales Outstanding ranked higher than
88.77% of 276 companies
in the Medical Devices industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
PODD: 41.78
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 28.65, Med: 56.54, Max: 82.7
Current: 41.78
28.65
82.7
Days Payable 49.28
Days Payable ranked higher than
68.20% of 261 companies
in the Medical Devices industry.
Industry Max: 912.5, Med: 58.34, Min: 1
PODD: 49.28
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 28.7, Med: 46.32, Max: 52.46
Current: 49.28
28.7
52.46

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -2.30
3-Year Share Buyback Rate ranked higher than
79.92% of 244 companies
in the Medical Devices industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
PODD: -2.3
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -354.5, Med: -7.55, Max: -0.9
Current: -2.3
-354.5
-0.9

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 38.14
Price-to-Tangible-Book ranked lower than
58.33% of 276 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 4.5, Min: 0.07
PODD: 38.14
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 3.41, Med: 33.13, Max: 1123
Current: 38.14
3.41
1123
Price-to-Median-PS-Value 1.60
Price-to-Median-PS-Value ranked higher than
50.21% of 237 companies
in the Medical Devices industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
PODD: 1.6
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.29, Med: 0.98, Max: 2.76
Current: 1.6
0.29
2.76
Price-to-Graham-Number 28.12
Price-to-Graham-Number ranked lower than
100.00% of 133 companies
in the Medical Devices industry.
Industry Max: 59.6, Med: 2.11, Min: 0.06
PODD: 28.12
Ranked among companies with meaningful Price-to-Graham-Number only.
Price-to-Graham-Number range over the past 10 years
Min: 24.89, Med: 37.08, Max: 49.27
Current: 28.12
24.89
49.27
Earnings Yield (Joel Greenblatt) % 0.65
Earnings Yield (Greenblatt) ranked higher than
63.25% of 332 companies
in the Medical Devices industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
PODD: 0.65
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -81.6, Med: -2.3, Max: 0.8
Current: 0.65
-81.6
0.8

More Statistics

Revenue (TTM) (Mil) $ 599.8
EPS (TTM) $ 0.23
Beta 0.98
Volatility % 40.19
52-Week Range $ 70.8 - 108.91
Shares Outstanding (Mil) 59.68

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N